|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> Tositumomab>> Market Analysis Reports |
Market Analysis Reports of Tositumomab |
|
Tositumomab (CAS 180288-69-1) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Radioimmunotherapy Market, Dosage, Price & Clinical Pipeline Outlook 2022 ... . Ibritumomab tiuxetan and Iodine (131I) tositumomab are the two most popular ... Zevalin(Ibriumomab tiuxetan) and Bexxar(Tositumomab). The excellent results obtained in cancer ... Cancer Monoclonal Antibodies Market to 2015 Globally, cancer is one of the leading causes of death, and accounted for almost 13% of total deaths in 2008. The cases of lung and breast cancers are expected to grow rapidly in the coming years. In order to treat the life-threatening disease more ... Cancer Monoclonal Antibodies Market Forecast to 2017 Cancer, one of the leading causes of death worldwide, affected approximately 13 Million people in 2012 and this figure is expected to grow to 17 Million by 2020. The dramatic increase in the size of the potential cancer market has prompted pharmaceutical ... Cancer CD Antigens Inhibitors Therapy Market & Pipeline Insight 2015 Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Pharmaceutical companies are continuously looking for better therapeutic options to effectively cure and prevent various malignancies. Several ... Global Cancer Immunotherapy Market Analysis & Forecast to 2022 Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors Within the cancer therapeutics space, which today is worth over $100 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that have high specificity for cancer cells. Today, cancer ... |